Beijing Aosaikang Pharmaceutical Co., Ltd.
SZSE:002755.SZ
8.79 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 1,443.46 | 1,872.572 | 3,106.667 | 3,782.689 | 4,518.632 | 3,931.882 | 365.934 | 178.358 | 278.157 | 470.869 | 500.425 | 494.258 | 529.171 |
| Kosten van de omzet
| 277.051 | 243.605 | 277.053 | 311.441 | 336.211 | 277.773 | 268.368 | 144.066 | 186.433 | 343.925 | 363.504 | 348.603 | 393.897 |
| Brutowinst
| 1,166.409 | 1,628.967 | 2,829.613 | 3,471.247 | 4,182.42 | 3,654.109 | 97.566 | 34.291 | 91.724 | 126.944 | 136.92 | 145.656 | 135.274 |
| Brutowinstmarge
| 0.808 | 0.87 | 0.911 | 0.918 | 0.926 | 0.929 | 0.267 | 0.192 | 0.33 | 0.27 | 0.274 | 0.295 | 0.256 |
| Onderzoek- en ontwikkelingskosten
| 472.008 | 588.838 | 324.447 | 255.891 | 310.104 | 290.268 | 18.068 | 8.929 | 18.188 | 13.291 | 19.445 | 16.23 | 0 |
| Algemene en administratieve kosten
| 55.594 | 46.165 | 52.852 | 51.837 | 63.066 | 55.191 | 11.732 | 4.726 | 6.625 | 6.945 | 7.008 | 8.737 | 41.703 |
| Verkoop- en marketingkosten
| 840.222 | 1,193.719 | 1,998.085 | 2,280.901 | 2,791.309 | 2,428.98 | 8.874 | 6.767 | 6.219 | 6.734 | 6.709 | 7.027 | 9.488 |
| Verkoop-, algemene en administratieve kosten
| 895.817 | 1,239.885 | 2,050.937 | 2,332.738 | 2,854.375 | 2,484.171 | 20.607 | 11.493 | 12.844 | 13.679 | 13.718 | 15.763 | 51.191 |
| Overige kosten
| 18.948 | 82.689 | 98.548 | 132.502 | 157.509 | 10.455 | 0.421 | 0.04 | -0.803 | 0.35 | -0.153 | 0.457 | 0.579 |
| Bedrijfskosten
| 1,424.593 | 1,911.412 | 2,473.932 | 2,721.131 | 3,321.989 | 2,929.015 | 68.066 | 40.151 | 57.77 | 59.845 | 65.522 | 67.394 | 70.658 |
| Bedrijfsresultaat
| -219.878 | -282.445 | 402.511 | 790.302 | 871.998 | 744.479 | 19.922 | 1.339 | 22.769 | 44.637 | 65.401 | 70.578 | 57.252 |
| Bedrijfsresultaat ratio
| -0.152 | -0.151 | 0.13 | 0.209 | 0.193 | 0.189 | 0.054 | 0.008 | 0.082 | 0.095 | 0.131 | 0.143 | 0.108 |
| Totaal overige inkomsten en kosten netto
| 18.948 | 19.941 | 3.56 | 30.897 | 15.936 | 29.84 | -9.156 | 10.505 | -10.936 | -22.14 | -5.746 | -6.992 | -6.815 |
| Inkomen voor belasting
| -200.929 | -262.504 | 406.071 | 821.198 | 887.933 | 754.934 | 20.343 | 4.645 | 23.017 | 44.958 | 65.653 | 71.269 | 57.802 |
| Inkomen voor belasting ratio
| -0.139 | -0.14 | 0.131 | 0.217 | 0.197 | 0.192 | 0.056 | 0.026 | 0.083 | 0.095 | 0.131 | 0.144 | 0.109 |
| Belastingkosten
| 6.55 | 3.701 | 25.506 | 95.83 | 108.032 | 86.031 | 3.082 | 0.041 | 4.152 | 7.454 | 10.132 | 11.315 | 8.666 |
| Nettowinst
| -148.53 | -266.206 | 379.908 | 721.625 | 780.959 | 670.074 | 10.967 | 4.605 | 18.865 | 37.504 | 55.521 | 59.954 | 49.135 |
| Nettowinstmarge
| -0.103 | -0.142 | 0.122 | 0.191 | 0.173 | 0.17 | 0.03 | 0.026 | 0.068 | 0.08 | 0.111 | 0.121 | 0.093 |
| WPA (Winst Per Aandeel)
| -0.16 | -0.29 | 0.41 | 0.78 | 0.84 | 0.89 | 0.8 | 0.029 | 0.12 | 0.29 | 0.43 | 0.46 | 0.38 |
| Verwaterde WPA
| -0.16 | -0.29 | 0.41 | 0.78 | 0.84 | 0.89 | 0.8 | 0.029 | 0.12 | 0.29 | 0.43 | 0.46 | 0.38 |
| EBITDA
| -127.063 | -153.466 | 497.167 | 909.876 | 989.371 | 842.661 | 48.896 | -5.57 | 50.581 | 94.748 | 82.337 | 90.375 | 72.325 |
| EBITDA ratio
| -0.088 | -0.082 | 0.16 | 0.241 | 0.219 | 0.214 | 0.134 | -0.031 | 0.182 | 0.201 | 0.165 | 0.183 | 0.137 |